Low muscle power linked to death risk in hemodialysis patients
In hemodialysis patients, low muscle power was linked to higher relative death risk than higher power over 24 months; the adjusted hazard ratio was 1.67.

Our read
Biomarkers- Studied:
- Cohort study of 922 adults on hemodialysis, against patients with higher muscle power
- What changed:
- Death risk was higher with low muscle power than higher power (adjusted hazard ratio 1.67)
- The catch:
- Poorer underlying health could contribute to both low muscle power and death risk
Editor of record: Boris Djordjevic · AgingResearch.News
Adults on hemodialysis—a blood-filtering treatment—were studied in a secondary analysis of the SARC-HD cohort. The 922 participants came from 19 Brazilian dialysis centers; 48.6% were at least 60 and 61.5% were male. Researchers estimated muscle power, the ability to produce force quickly, using a test of standing up from a chair five times. They expressed power relative to body weight and defined low power as the bottom third within age and sex groups.
Over 24 months, 12.8% died and 35.4% were hospitalized. Low power was linked to greater mortality after adjustment for clinical factors, but not to hospitalization. The mortality link was particularly strong among patients aged 60 or older, with an adjusted hazard ratio of 2.19. Younger patients had no clear link; their estimate of 1.02 had a range of likely values that included no difference.
Why it matters
Low muscle power predicts poor outcomes in older adults. The authors suggest it may also be a relevant aging-related condition in people on hemodialysis.
Caveats
Poorer underlying health may have contributed to both low muscle power and death risk despite statistical adjustment. The cohort covered adults receiving hemodialysis, not people with kidney disease who were not receiving it.
The paper
Low Muscle Mechanical Power, Worse Clinical Outcomes? A Cohort of Patients on Hemodialysis
Sao Paulo State University; University of Brasilia
Medicine and Science in Sports and Exercise, Nov 10, 2026




Comments
Be the first to comment.